Trick of the Trade: IV ceftriaxone for gonorrhea

Clinician administering an intramuscular ceftriaxone injection into a patient's upper arm

How many times have you given your patient IM ceftriaxone for that presumed gonococcal infection? … still counting? Many of us learned (or at least thought we learned) that ceftriaxone has to be administered IM to get the ‘depot’ effect.

Myth Busted

There doesn’t appear to be a true depot effect. IV and IM ceftriaxone have very similar pharmacokinetic profiles. Let me prove it to you, straight from the FDA-approved ceftriaxone package insert.

Ceftriaxone route	0.5 hr	1 hr	2 hr	4 hr	6 hr	8 hr	12 hr	16 hr	24 hr
IV	82	59	48	37	29	23	15	10	5
IM	22	33	38	35	30	26	16	unknown	5

Table 1: Average plasma concentration (mcg/mL) as measured over time after 500 mg of ceftriaxone administration

Ceftriaxone route	0-2 hrs	2-4 hrs	4-8 hrs	8-12 hrs	12-24 hrs	24-48 hrs
IV	526	366	142	87	70	15
IM	115	425	308	127	96	28

Table 2: Average urine concentration (mcg/mL) as measured over time after 500 mg of ceftriaxone administration

The plasma concentrations are almost identical after IM and IV administration through 24 hours (Table 1).
Even the urinary concentrations are similar up to 24-48 hours after a dose (Table 2).
The volume of distribution is the same for both parenteral routes, too. This means that its penetration into the “affected area” is similar.
According to a 2012 CDC Report the minimum inhibitory concentration (MIC) for N. gonorrhoeae strains to ceftriaxone is 0.125 mcg/mL. IV therapy provides concentrations above this resistance cutoff well after 24-48 hours, similar to IM therapy.

Trick of the Trade

If the patient already has an IV line, we can give IV ceftriaxone for gonorrhea instead of IM.

In fact, the Japanese Society for Sexually Transmitted Diseases has recommended monotherapy with a single IV dose of 1 g ceftriaxone since 2008. (Aoki 2021)

While most of the time patients with STD (or STI, if you prefer) complaints don’t have an IV line established, occasionally they do. My hospital stocks 1 gm and 2 gm premixed IV bags of ceftriaxone, so we could potentially just give 1 gm IV in these rare cases to ensure adequate levels (even 500 mg might be just fine).

Of course, the other way to avoid the painful injection is to mix the ceftriaxone with lidocaine… or avoid contracting gonorrhea altogether.

Disclaimer

This post is intended for educational purposes to explore the kinetic data for IM and IV therapy. The CDC guidelines should be followed for treatment of STDs.

2026 editor’s update: Current CDC guidance (the 2021 STI Treatment Guidelines, still in effect) recommends a single dose of ceftriaxone 500 mg IM (1 g IM if ≥150 kg) as monotherapy for uncomplicated gonorrhea — up from the 250 mg dose referenced in the 2010 guidelines cited below. Add doxycycline 100 mg PO twice daily for 7 days if chlamydia coinfection hasn’t been excluded. The IV/IM equivalence data below still holds — only the recommended dose has changed.

References

Product Information: ROCEPHIN(R) IV, IM injection, ceftriaxone sodium IV, IM injection. Genentech USA, Inc. (per Manufacturer), South San Francisco, CA, 2010.
Workowski KA, Bachmann LH, Chan PA, et al.; Centers for Disease Control and Prevention (CDC). Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(4):1-187. [PMID: 34292926]. Free CDC PDF download.

Original: October 9, 2012; Last Updated: August 10, 2026

Bio
Twitter
Facebook
Latest Posts

Bryan D. Hayes, PharmD, DABAT, FAACT, FASHP

Leadership Team, ALiEM
Creator and Lead Editor, Capsules and EM Pharm Pearls Series
Attending Pharmacist, EM and Toxicology, MGH
Associate Professor of EM, Division of Medical Toxicology, Harvard Medical School